Shalabh Singhal
- Rheumatology top 5%
- Immunology
- Cardiology and Cardiovascular Medicine
- Oncology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Subhashis BanerjeeAlan KivitzPhilip J. MeaseMiroslawa NowakFrank BehrensAtul DeodharIan M. CatlettDésirée van der Heijde
- Topics
- Atrial Fibrillation Management and Outcomes (9 papers)Systemic Lupus Erythematosus Research (8 papers)Cytokine Signaling Pathways and Interactions (8 papers)
- Journals
- New England Journal of MedicineCirculationSHILAP Revista de lepidopterología
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Shalabh Singhal
32 papers receiving 460 citations
Hit Papers
Peers
Comparison fields: 5 of 47
- Rheumatology 208
- Immunology 198
- Cardiology and Cardiovascular Medicine 124
- Oncology 114
- Radiology, Nuclear Medicine and Imaging 60
Countries citing papers authored by Shalabh Singhal
This map shows the geographic impact of Shalabh Singhal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalabh Singhal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalabh Singhal more than expected).
Fields of papers citing papers by Shalabh Singhal
This network shows the impact of papers produced by Shalabh Singhal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalabh Singhal. The network helps show where Shalabh Singhal may publish in the future.
Co-authorship network of co-authors of Shalabh Singhal
This figure shows the co-authorship network connecting the top 25 collaborators of Shalabh Singhal. A scholar is included among the top collaborators of Shalabh Singhal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shalabh Singhal. Shalabh Singhal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritisbreakdown → | 134 |
| 10 | Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase | 139 |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 1 | |
| 14 | 2 | |
| 15 | 13 | |
| 16 | 2 | |
| 17 | 3 | |
| 18 | 5 | |
| 19 | 6 | |
| 20 | 77 |
About Shalabh Singhal
Shalabh Singhal is a scholar working on Internal Medicine, Rheumatology and Cardiology and Cardiovascular Medicine, having authored 34 papers that have together received 463 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Cytokine Signaling Pathways and Interactions (8 papers). The work is most often cited by research in Rheumatology (208 citations), Internal Medicine (38 citations) and Immunology (198 citations). Shalabh Singhal has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Subhashis Banerjee, Alan Kivitz, Philip J. Mease, Miroslawa Nowak, Frank Behrens, Atul Deodhar, Ian M. Catlett, Désirée van der Heijde, Jeffrey Neal and Jonghyeon Kim. Their work appears in journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.